Institutional investors purchased a net $745.3 thousand shares of NVO during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 9.65% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Major industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HARDING LOEVNER LP Bought 166.3 Thousand shares of Novo Nordisk
CHAUTAUQUA CAPITAL MANAGEMENT LL... Bought 131.5 Thousand shares of Novo Nordisk
CURIAN CAPITAL LLC Bought 105.5 Thousand shares of Novo Nordisk